drugset / Trial / NCT01492192
RGD-PET-CT in Cancer Angiogenesis
Phase 2
Terminated
10 enrolled
Oxford University Hospitals NHS Trust
GE Healthcare · collabUniversity of Oxford · collab
NaSingle-groupOpen-labelDiagnostic
Summary
The goal of this clinical research study is to look at 2 new methods of scanning and see whether they can help researchers predict which tumours will respond to drugs that attack tumour blood supply.
Timeline
- Start
- 2013-05
- Primary completion
- 2015-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluciclatide | Peptide | 400 mbq | Other |